Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
38.5 USD | -2.28% | -2.89% | +10.63% |
Apr. 29 | UBS Trims Lazard Price Target to $43 From $44, Maintains Neutral Rating | MT |
Apr. 26 | Tranche Update on Lazard, Inc.'s Equity Buyback Plan announced on May 1, 2014. | CI |
Financials (USD)
Sales 2024 * | 2.93B | Sales 2025 * | 3.18B | Capitalization | 3.47B |
---|---|---|---|---|---|
Net income 2024 * | 240M | Net income 2025 * | 383M | EV / Sales 2024 * | 1.82 x |
Net Debt 2024 * | 1.85B | Net Debt 2025 * | 1.69B | EV / Sales 2025 * | 1.62 x |
P/E ratio 2024 * |
15.9
x | P/E ratio 2025 * |
9.88
x | Employees | 3,114 |
Yield 2024 * |
5.19% | Yield 2025 * |
5.38% | Free-Float | 78.82% |
Latest transcript on Lazard
1 day | -2.28% | ||
Current month | -1.23% | ||
6 months | +37.94% | ||
Current year | +10.63% |
Managers | Title | Age | Since |
---|---|---|---|
Peter Orszag
CEO | Chief Executive Officer | 55 | 16-05-30 |
Raymond McGuire
PSD | President | 66 | 23-04-02 |
Mary Ann Betsch
DFI | Director of Finance/CFO | 45 | 22-10-02 |
Members of the board | Title | Age | Since |
---|---|---|---|
Richard Parsons
BRD | Director/Board Member | 76 | 12-06-12 |
Daniel Schulman
BRD | Director/Board Member | 66 | Jan. 31 |
Kenneth Jacobs
CHM | Chairman | 65 | 87-12-31 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
0.19% | 45 M€ | -1.28% | ||
0.11% | 237 M€ | +1.29% | - |
Date | Price | Change | Volume |
---|---|---|---|
24-04-30 | 38.5 | -2.28% | 472,499 |
24-04-29 | 39.4 | +1.05% | 977,104 |
24-04-26 | 38.99 | +0.26% | 798,552 |
24-04-25 | 38.89 | -1.04% | 1,441,820 |
24-04-24 | 39.3 | -0.87% | 1,106,733 |
Delayed Quote Nyse, April 30, 2024 at 04:00 pm EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-7.04% | 112B | |
-7.01% | 84.95B | |
+16.30% | 61.67B | |
+3.89% | 60.84B | |
+8.53% | 42.24B | |
+8.41% | 41.01B | |
+18.10% | 34.74B | |
+1.75% | 24.47B | |
+0.60% | 18.61B |
- Stock Market
- Equities
- LAZ Stock
- LAZ Stock